Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 15, 2026
Why Is POET Technologies (POET) Stock Down -17% Today?

Why Is POET Technologies (POET) Stock Down -17% Today?

Key Takeaways

  • Shares of POET fell approximately 17% in premarket trading on May 15, 2026, extending a volatile session following an overnight earnings release
  • The primary catalyst is a Q1 2026 EPS miss: POET reported a GAAP loss of -$0.08 per share, falling short of the consensus estimate of -$0.05 by $0.03, or roughly 60% worse than expected
  • A partial offset came from a revenue beat — the company posted $0.5 million in Q1 revenue, a 194% year-over-year increase that exceeded expectations by $0.25 million
  • Also on May 15, POET announced a new partnership with Lumilens to advance wafer-level photonic integration for AI optical networks, which provided some intraday support but did not prevent the initial plunge
  • The stock has been extremely volatile in recent months, staging a dramatic multi-week rally following a 49% crash in late April tied to the loss of Marvell-related orders
  • Traders are watching the formal Q1 earnings call and any updated commentary on commercialization timelines, customer order pipeline, and management guidance for the remainder of 2026

Opening Summary

POET Technologies Inc. (POET) is a Toronto-based fabless semiconductor company developing Optical Interposer platform technology — a novel approach to integrating electronic and photonic devices — primarily targeting AI data center optical networking applications. Shares dropped roughly 17% in premarket trading on May 15, 2026, from a prior session close of approximately $25.40, touching an intraday low near $13.90 before recovering sharply. The immediate trigger was the release of Q1 2026 earnings, in which the company reported a loss wider than analysts expected on a per-share basis, even as revenue surpassed forecasts. The earnings-driven move reflects investor sensitivity to profitability metrics in a stock that has already experienced extreme volatility in recent weeks.

Q1 2026 Earnings — The Primary Catalyst

The core driver of today's selloff is POET's Q1 2026 financial results, released before the opening bell on May 15, 2026. The company posted a GAAP EPS of -$0.08, missing the consensus estimate of -$0.05 by $0.03 — a shortfall of approximately 60% relative to expectations. For a pre-revenue-stage company whose valuation is almost entirely speculative and sentiment-driven, an EPS miss of this magnitude can sharply reset investor expectations, particularly after a sustained price rally.

On the revenue side, POET delivered $0.5 million in quarterly revenue, representing a 194.1% year-over-year increase and beating the consensus revenue estimate by $0.25 million. While the revenue beat demonstrates early commercial traction for the company's optical engine technology, the absolute dollar figure remains small relative to the company's market capitalization, and the wider net loss underscored that POET remains firmly in investment mode with significant operating expenses ahead of it.

New Lumilens Partnership — The Silver Lining

Partially tempering the earnings-driven selloff, POET also announced on May 15 a technology partnership with Lumilens to advance wafer-level photonic integration for next-generation AI optical networks. An analyst video review from May 14 noted that a deal tied to the Lumilens relationship involved an initial order valued at approximately $50 million, with the broader partnership potentially expanding over several years depending on development and production milestones. Warrants granted to Lumilens as part of the agreement could introduce additional dilution risk down the line, a consideration that sophisticated investors are beginning to price in.

The partnership reinforces POET's commercial narrative around AI optical connectivity, but the market's reaction suggests that near-term execution — specifically on the path to sustained, recurring revenue — matters more to investors at current valuation levels than further strategic announcements.

Volatile Recent History

Today's decline must be understood in the context of POET's extraordinary recent price history. In late April 2026, the stock cratered nearly 50% after MRVL (Marvell Technology) canceled all purchase orders previously placed through its Celestial AI acquisition, following a dispute over POET's public disclosure of order details. The stock then staged a strong recovery of approximately 50% in the first week of May, driven by unconfirmed speculation linking POET to potential interest from QCOM (Qualcomm) and ongoing enthusiasm around its photonic platform. That volatile backdrop means the stock entered today's session elevated and vulnerable to any negative surprise in the earnings print.

Market Context and Trading Activity

Trading volume in POET is running well above its average daily levels, consistent with prior high-volatility sessions around major news events. The stock swung from a premarket-driven low of $13.90 to an intraday high of $25.68 on May 15 — a range of nearly 85% within a single session — reflecting the speculative, retail-driven nature of POET's current shareholder base. Broader semiconductor and photonics peers did not exhibit similar volatility, suggesting the price action is idiosyncratic to POET rather than a sector-wide move. The high short interest in the stock — near record levels in recent weeks — is amplifying both the downside moves and the intraday recovery bounces.

Trending AI Robots

Navigating a stock like POET — with its sharp intraday swings and sentiment-driven volatility — requires disciplined, rules-based approaches that remove emotion from execution. Tickeron's Trending AI Robots page showcases a curated selection of the platform's top-performing AI trading bots under current market conditions. Tickeron runs hundreds of AI-powered bots covering thousands of tickers, but only those demonstrating the strongest live performance metrics are featured in this section. Bots vary in strategy (momentum, mean reversion, breakout), timeframe, risk tolerance, and the specific symbols they trade. Traders looking for a data-driven edge in today's volatile markets may find it worthwhile to explore what the Trending AI Robots section currently has to offer.

What Comes Next for POET

The formal earnings call and any updated management guidance on customer order pipelines, manufacturing ramp timelines, and revenue visibility for the second half of 2026 will be closely watched by investors in the sessions ahead. Engineering samples from the Lumilens partnership are expected in late 2026, with production timing tied to customer deployment schedules in 2027, meaning near-term revenue contributions from this deal remain limited. Analyst coverage of POET remains sparse, and the absence of formal sell-side consensus leaves the stock highly susceptible to retail sentiment and social media-driven narratives.

Key risks include continued dilution from future capital raises — POET has already completed several large registered direct offerings in 2025 and early 2026  — ongoing net losses, the absence of significant recurring revenue, and the potential for further customer relationship disruptions similar to the Marvell episode. The warrants associated with the Lumilens deal could also add to share count over time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: POET

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


POET's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for POET just turned positive on July 30, 2026. Looking at past instances where POET's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where POET advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on POET as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

POET moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

POET broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for POET entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. POET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.685) is normal, around the industry mean (7.465). P/E Ratio (0.000) is within average values for comparable stocks, (155.851). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.777). POET has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). POET's P/S Ratio (833.333) is very high in comparison to the industry average of (53.922).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 196.39B. The market cap for tickers in the group ranges from 13.43K to 5.2T. NVDA holds the highest valuation in this group at 5.2T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -8%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 37%. ICG experienced the highest price growth at 16%, while MXL experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
POET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Profile
Details
Industry
N/A
Address
120 Eglinton Avenue East
Phone
+1 416 368-9411
Employees
90
Web
https://www.poet-technologies.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.